CD33 and early-onset autosomal dominant Alzheimer disease: Because the pathogenic nature of CD33 in Alzheimer’s disease is often thought to be related to the inhibition of phagocytosis resulting in diminished Aβ clearance and consequent neurodegeneration, the mechanism underlying the enhancement of CD33 SNP effects by HBV and HCV could be linked to phagocytosis inhibition.